Gates GA, Green JD. Intermittent pressure therapy of intractable Ménière's disease using the Meniett device: a preliminary report.
Laryngoscope 2002;
112:1489-93. [PMID:
12172267 DOI:
10.1097/00005537-200208000-00029]
[Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
HYPOTHESIS
Treatment with the Meniett device, which applies intermittent micropressure pulses to the inner ear through a tympanostomy tube, is effective in controlling vertigo in people with intractable Ménière's disease.
STUDY DESIGN
Short-term, preliminary descriptive report.
METHODS
Ten patients with intractable vertigo despite adequate medical therapy elected to use the Meniett device. After placement of a standard tympanostomy tube, the patient self-administers the Meniett device three times daily.
RESULTS
The follow-up ranged from 3 to 11 months with an average of 8 months. All 10 patients responded to the therapy with vertigo control in 9 of 10 and a 50% reduction in the 10th case. There was a mean hearing gain of 6 dB, which was statistically significant. There were no major complications. Two subjects required tube reinsertion during the 8 months of follow-up.
CONCLUSIONS
Use of the Meniett device is an effective and safe option for people with intractable vertigo from Ménière's disease.
Collapse